2027 PharmaTech & Clinical Trials Innovation Award

Revolutionizing Drug Discovery and Development with Technology.

The 2027 HealthTechNode PharmaTech & Clinical Trials Innovation Award recognizes technologies and platforms transforming how therapies are discovered, developed, tested, and brought to market. This award honors innovations that improve research strategy, trial execution, evidence generation, regulatory readiness, and the broader pharmaceutical development lifecycle.

Drug development depends on better data, more efficient operations, stronger participant experiences, and faster access to credible evidence. AI, analytics, automation, decentralized research tools, and real-world data can help sponsors, research organizations, sites, and investigators answer important questions with greater speed and rigor.

This award celebrates solutions producing practical value across pharmaceutical and clinical research workflows. Strong entries will demonstrate improvements in discovery, trial design, recruitment, data quality, operational efficiency, evidence generation, or measurable outcomes.

Entry Schedule

• Entries Open: July 13, 2027
• Early Bird Deadline: August 6, 2027
• Final Entry Deadline: September 10, 2027
• Winners Announced: September 20, 2027

Entry Fees

• Early Bird Entry: $395
• Regular Entry: $495

Who Should Enter

• Companies building technology for drug discovery, development, or clinical research
• Organizations advancing trial operations, recruitment, engagement, or data management
• Teams using AI, analytics, automation, or real-world evidence in life sciences
• Sponsors, CROs, sites, and partners implementing innovative research workflows
• Companies demonstrating measurable value across pharmaceutical or clinical trial programs

What Judges Will Consider

• Demonstrated value in improving drug development, research execution, or evidence generation
• Strength of the innovation, usability, and implementation approach
• Evidence of efficiency, quality, adoption, participant benefit, or measurable impact
• Ability to support responsible use across real-world research workflows
• Clear differentiation within the PharmaTech and clinical trials landscape

Eligibility

• Open to companies, startups, organizations, and teams operating in health technology worldwide
• Entries should highlight work developed, released, updated, expanded, or significantly advanced during 2027
• Submissions should include supporting evidence that clearly demonstrates the innovation’s value and impact

Entry fees are charged at submission and are non-refundable. Customer or client identity should be included in your submission. If you need names excluded from public materials, notify us in writing at the time of submission. By submitting, you agree to the Submission Guidelines, Privacy Policy, and Terms and Conditions. HealthTechNode Awards are independent and unaffiliated with other award programs.